# Johnson & Johnson (JNJ) — Q3-2011 Earnings Results

**Report date:** 2011-10-18 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2011

## Post-Earnings Brief

### Headline

Johnson & Johnson Misses on EPS — Stock Up 0.99%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.15 | N/A | -4.80% |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management remains focused on strategic initiatives to drive future performance. They acknowledged the challenges faced in the quarter but expressed confidence in their long-term vision.

**Key quotes:**

> Management emphasized their commitment to long-term growth despite the EPS miss.

> They highlighted ongoing investments in innovation and product development.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

The earnings report indicates that Johnson & Johnson's EPS fell short of expectations, which could raise concerns among investors. However, the stock reacted positively, rising by nearly 1%. This suggests that investors may be looking beyond the EPS miss, focusing instead on the company's long-term growth strategy and commitment to innovation.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/JNJ/earnings/Q3-2011_